Jul 3, 2024, 02:35
Rahul Banerjee: Fascinating small Ph2 trial on relapsed or refractory multiple myeloma
Rahul Banerjee, Assistant Professor at UW Medicine, made the following post on X:
“Absolutely abscopal responses …. in myeloma??
Fascinating small Ph2 trial in The Lancet Haematology by Khan Sagar Lonial et al:
Pembro q3wk + 1 Fx RT to EMD sites… 7/25 responders, inc. 2 CRs. Better than I might’ve guessed for pembro monoTx in multiple myeloma.”
Read further.
Source: Rahul Banerjee/X